Cargando…
A High-Throughput HIV-1 Drug Screening Platform, Based on Lentiviral Vectors and Compatible with Biosafety Level-1
HIV-1 infection is a complex, multi-step process involving not only viral, but also multiple cellular factors. To date, drug discovery methods have primarily focused on the inhibition of single viral proteins. We present an efficient and unbiased approach, compatible with biosafety level 1 (BSL-1) c...
Autores principales: | Ellinger, Bernhard, Pohlmann, Daniel, Woens, Jannis, Jäkel, Felix M., Reinshagen, Jeanette, Stocking, Carol, Prassolov, Vladimir S., Fehse, Boris, Riecken, Kristoffer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290285/ https://www.ncbi.nlm.nih.gov/pubmed/32466195 http://dx.doi.org/10.3390/v12050580 |
Ejemplares similares
-
High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1
por: Kuzikov, Maria, et al.
Publicado: (2022) -
A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analyses
por: Prokofjeva, Maria M, et al.
Publicado: (2013) -
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases
por: Mock, Ulrike, et al.
Publicado: (2014) -
Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
por: Badbaran, Anita, et al.
Publicado: (2021) -
Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer
por: Bierwolf, Jeanette, et al.
Publicado: (2016)